PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17103462-0	2007	The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats.	Streptozocin	67-81	insulin 2	Rattus norvegicus	4-13	
17103462-5	2007	This study was designed to elucidate the effects of the C-peptide fragment EVARQ on kidney function, blood pressure and blood glucose levels in diabetic rats in vivo.	Blood Glucose	120-133	insulin 2	Rattus norvegicus	56-65	
17103462-12	2007	Furthermore, blood pressure was only reduced in diabetic rats that were given C-peptide, whereas the blood glucose decreased in the diabetic groups that were given either C-peptide or EVARQ.	Blood Glucose	101-114	insulin 2	Rattus norvegicus	171-180	
17103462-13	2007	CONCLUSIONS: The present study shows that administration of the C-peptide fragment EVARQ has similar effects on GFR and blood glucose levels as the intact C-peptide molecule, suggesting at least one active site within this region.	Glucose	126-133	insulin 2	Rattus norvegicus	64-73